<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Arbutus Biopharma Corporation

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Arbutus Biopharma Corporation

    Arbutus Biopharma is a publicly-traded (NASDAQ:ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      William H. Collier
    • FOUNDED
      1992
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Powell Development Group Inc.

    Powell Development Group Inc.

    After a good friend contracted HIV, I thought how could this happen? I was both sh...

    After a good friend contracted HIV, I thought h...

    Amount Raised:    $163,741.76
    Fundraising Status:    EC
    Filing Type:    CF
    BioCardia, Inc.

    BioCardia, Inc.

    BioCardia, Inc., headquartered in San Carlos, California, is developing regenerati...

    BioCardia, Inc., headquartered in San Carlos, C...

    Filing Type:    PU
    Iovance Biotherapeutics, Inc.

    Iovance Biotherapeutics, Inc.

    Iovance Biotherapeutics (formerly traded as Lion Biotechnologies) is focused on th...

    Iovance Biotherapeutics (formerly traded as Lio...

    Filing Type:    PU
    YiLoLife Inc

    YiLoLife Inc

    YiLo Life uses organic methods and the finest ingredients to create cannabis produ...

    YiLo Life uses organic methods and the finest i...

    Fundraising Status:    EC
    Filing Type:    RA
    Aclaris Therapeutics, Inc.

    Aclaris Therapeutics, Inc.

    Since Aclaris was founded in 2012, our focus has been innovation to help people wi...

    Since Aclaris was founded in 2012, our focus ha...

    Filing Type:    PU
    Viking Therapeutics, Inc.

    Viking Therapeutics, Inc.

    Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the d...

    Viking Therapeutics is a clinical-stage biophar...

    Filing Type:    PU
    Benitec Biopharma Limited

    Benitec Biopharma Limited

    Benitec is a biotechnology company developing a proprietary therapeutic technology...

    Benitec is a biotechnology company developing a...

    Filing Type:    PU
    Spring Bank Pharmaceuticals, Inc.

    Spring Bank Pharmaceuticals, Inc.

    Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery...

    Spring Bank is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Assembly Biosciences, Inc.

    Assembly Biosciences, Inc.

    Assembly Biosciences is advancing a new class of oral therapeutics for the treatme...

    Assembly Biosciences is advancing a new class o...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.